Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02593526 · ClinicalTrials.gov registry record · NA
Diuretic/Cool Dialysate Trial
A NA study, sponsored by University of New Mexico.
- Terminated
- Registry status
- NA
- Development phase
- 11
- Enrollment target
NCT02593526 is a NA study that was terminated before completion, run by University of New Mexico. The registered enrollment target is 11 participants.
The verdict
NCT02593526, a NA study, was terminated before completion, sponsored by University of New Mexico.
- TERMINATED
- Registry status
- NA
- Development phase
- 11 participants
- Enrollment target
Study Summary
The proposed pilot study challenges the current widespread paradigm of discontinuing loop diuretics when initiating chronic HD and/or maintaining the dialysate at a constant temperature of 37 °C for all patients.
Interventions
- DRUG Bumetanide
- OTHER Cool Dialysate
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 11 participants |
| Start Date | 2017-01 |
| Est. Completion | 2022-05-27 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02593526
The ClinicalTrials.gov registry entry for NCT02593526 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 11 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of New Mexico, which has 168 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Bumetanide is the first listed.
NCT02593526 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02593526 about?
NCT02593526 is a clinical study titled "Diuretic/Cool Dialysate Trial". The proposed pilot study challenges the current widespread paradigm of discontinuing loop diuretics when initiating chronic HD and/or maintaining the dialysate at a constant temperature of 37 °C for all patients.
What is the current status of trial NCT02593526?
This trial is currently terminated. It is a NA study. The enrollment target is 11 participants. The study started on 2017-01. Estimated completion is 2022-05-27.
What interventions are being tested in trial NCT02593526?
The interventions under investigation include: Bumetanide (DRUG), Cool Dialysate (OTHER).
Who is sponsoring clinical trial NCT02593526?
This trial is sponsored by University of New Mexico, which has 168 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.